This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 909385
Submitted by lobbyist on: January 29, 2019 06:30:00 PM
Accepted by Registrar on: January 30, 2019 09:21:44 AM
Designated Filer Information
| Robidoux, Michel |
| 110 rue de Lauzon | |
|
Boucherville, QC, J4B 1E6
|
450-641-4903 |
| Canada |
Organization Information
| Sandoz Canada |
| Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people's lives. For further information please visit www.sandoz.ca |
| 110 rue de Lauzon | |
|
Boucherville, BC, J4B 1E6
|
450-641-4903 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Sandoz Canada |
110 rue de Lauzon
Boucherville, QC J4B 1E6 Canada |
Phone: 450-641-4903 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| January 29, 2019 | |
| July 29, 2019 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raisins awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients. Raise awareness of digital treatment solutions to treat patients with addictions.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Darcy, Judy | Minister of Mental Health and Addictions | April 8, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 8, 2019 |
| Minister | Horgan, John | Premier | April 8, 2019 |
| Minister | James, Carole | Minister of Finance | April 8, 2019 |
| MLA | Isaacs, Joan | Coquitlam-Burke Mountain | April 8, 2019 |
| MLA | Letnick, Norm | Kelowna-Lake Country | April 8, 2019 |
| Public Agency | Health | April 8, 2019 | |
| Public Agency | Mental Health and Addictions | April 8, 2019 | |
| Public Agency | The University of British Columbia | April 8, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Raising awareness of government officials of generic product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for generics. Raise awareness of digital treatment solutions to treat patients with addictions
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | January 29, 2019 | |
| Public Agency | Mental Health and Addictions | January 29, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Raising awareness of government officials of biosimilars product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for biosimilars
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Dix, Adrian | Minister of Health | April 8, 2019 |
| Staff of Minister | Singh, Jasmyn | Minister of Health | April 8, 2019 |
| Public Agency | Health | April 8, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raisins awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients. Raise awareness of digital treatment solutions to treat patients with addictions.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Darcy, Judy | Minister of Mental Health and Addictions | January 29, 2019 |
| Minister | Dix, Adrian | Minister of Health | January 29, 2019 |
| Minister | Horgan, John | Premier | January 29, 2019 |
| Minister | James, Carole | Minister of Finance | January 29, 2019 |
| Staff of Minister | Singh, Jasmyn | Minister of Health | April 8, 2019 |
| MLA | Isaacs, Joan | Coquitlam-Burke Mountain | January 29, 2019 |
| MLA | Letnick, Norm | Kelowna-Lake Country | January 29, 2019 |
| MLA | Yap, John | Richmond-Steveston | April 8, 2019 |
| Public Agency | Health | January 29, 2019 | |
| Public Agency | Mental Health and Addictions | January 29, 2019 | |
| Public Agency | The University of British Columbia | January 29, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Raising awareness of government officials of biosimilars product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for biosimilars
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | January 29, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raisins awareness to government officials of generics and Biosimilars products development by Sandoz Canada and the potential savings realized by healthcare system. Improve regulatory environment and utilization rates for generics and Biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients. Raise awareness of digital treatment solutions to treat patients with addictions.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Darcy, Judy | Minister of Mental Health and Addictions | April 8, 2019 |
| Minister | Dix, Adrian | Minister of Health | April 8, 2019 |
| Minister | Horgan, John | Premier | April 8, 2019 |
| Minister | James, Carole | Minister of Finance | April 8, 2019 |
| MLA | Isaacs, Joan | Coquitlam-Burke Mountain | April 8, 2019 |
| MLA | Letnick, Norm | Kelowna-Lake Country | April 8, 2019 |
| Public Agency | Health | April 8, 2019 | |
| Public Agency | Mental Health and Addictions | April 8, 2019 | |
| Public Agency | The University of British Columbia | April 8, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Raising awareness of government officials of biosimilars product development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rate for biosimilars
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | January 29, 2019 | |
| Public Agency | Provincial Health Services Authority | April 8, 2019 | |
| Public Agency | The University of British Columbia | April 8, 2019 |